呼吸器デバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界の呼吸器デバイスの市場規模は、2024年から2030年までの予測期間中に10.50％のCAGRで拡大すると予測されています。呼吸器デバイス市場は、喘息、慢性閉塞性肺疾患（COPD）、気管支炎、肺がんなどの呼吸器疾患の発生率の上昇、COVID-19パンデミックの発生、低侵襲手技の採用の増加、製品開発における急速な技術革新、それによって2024年から2030年までの予測期間中に呼吸器デバイス市場の成長に寄与することによって、プラスの成長が見込まれています。

COVID-19パンデミックの発生により、呼吸器デバイス市場は大幅に上昇し、需要が大幅に増加しています。

世界中でCOVID-19感染者が増え続けていることから、呼吸器デバイスの需要は倍増すると予想されています。例えば、世界保健機関（WHO）によると、2022年2月14日現在、COVID-19の確定症例は410,565,868件です。

さらに上記のデータでは、米国、インド、ブラジル、英国、フランスの5カ国がCOVID-19の深刻な影響を受けていることも述べられています。

さらに、2022年11月24日に南アフリカからWHOに初めて報告されたオミクロン変種のような新型の出現も、家庭での早期スクリーニングのために、さまざまな国の間で呼吸器デバイスの採用を増加させる可能性があります。

さらに、COVID-19の管理における呼吸器デバイスの応用に関する人々の意識の高まりも、世界の呼吸器デバイス市場の成長を促進しています。

当レポートでは、世界の呼吸器デバイス市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 呼吸器デバイス市場レポートのイントロダクション

第2章 呼吸器デバイス市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 呼吸器デバイス市場の主な要因分析

• 呼吸器デバイス市場の促進要因
• 呼吸器デバイス市場の抑制要因と課題
• 呼吸器デバイス市場の機会

第5章 呼吸器デバイス市場におけるポーターのファイブフォース分析

第6章 呼吸器デバイス市場に対するCOVID-19の影響分析

第7章 呼吸器デバイス市場概要

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 呼吸器デバイスの世界企業シェア分析-主要3～5社

第9章 呼吸器デバイスの企業と製品プロファイル

• PENTAX Medical
• Boston Scientific Corporation
• Medtronic
• Ambu A/S
• CONMED Corporation
• Koninklijke Philips N.V.
• Cook
• Medi-Globe GmbH
• Getinge AB
• ResMed
• KARL STORZ SE & Co. KG
• Verathon Inc
• Olympus Corporation
• Richard Wolf GmbH
• FUJIFILM Corporation
• Dragerwerk AG & Co. KGaA
• Smiths Group PLC
• SCHILLER AG
• General Electric Company
• ACE Medical Devices Pvt. Ltd.

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis in Pulmonology Devices Market
• Table 3: Pulmonology Devices Market in Global (2021-2030)
• Table 4: Pulmonology Devices Market in Global by Product Type (2021-2030)
• Table 5: Pulmonology Devices Market in Global by End User (2021-2030)
• Table 6: Pulmonology Devices Market in Global by Geography (2021-2030)
• Table 7: Pulmonology Devices Market in North America (2021-2030)
• Table 8: Pulmonology Devices Market in North America by Product Type (2021-2030)
• Table 9: Pulmonology Devices Market in North America by End User (2021-2030)
• Table 10: Pulmonology Devices Market in North America by Country (2021-2030)
• Table 11: Pulmonology Devices Market in the US (2021-2030)
• Table 12: Pulmonology Devices Market in Canada (2021-2030)
• Table 13: Pulmonology Devices Market in Mexico (2021-2030)
• Table 14: Pulmonology Devices Market in Europe (2021-2030)
• Table 15: Pulmonology Devices Market in Europe by Product Type (2021-2030)
• Table 16: Pulmonology Devices Market in Europe by End User (2021-2030)
• Table 17: Pulmonology Devices Market in Europe by Country (2021-2030)
• Table 18: Pulmonology Devices Market in France (2021-2030)
• Table 19: Pulmonology Devices Market in Germany (2021-2030)
• Table 20: Pulmonology Devices Market in UK (2021-2030)
• Table 21: Pulmonology Devices Market in Italy (2021-2030)
• Table 22: Pulmonology Devices Market in Spain (2021-2030)
• Table 23: Pulmonology Devices Market in Russia (2021-2030)
• Table 24: Pulmonology Devices Market in Rest of Europe (2021-2030)
• Table 25: Pulmonology Devices Market in Asia Pacific (2021-2030)
• Table 26: Pulmonology Devices Market in Asia Pacific by Product Type (2021-2030)
• Table 27: Pulmonology Devices Market in Asia Pacific by End User (2021-2030)
• Table 28: Pulmonology Devices Market in Asia Pacific by Country (2021-2030)
• Table 29: Pulmonology Devices Market in China (2021-2030)
• Table 30: Pulmonology Devices Market in Japan (2021-2030)
• Table 31: Pulmonology Devices Market in India (2021-2030)
• Table 32: Pulmonology Devices Market in Australia (2021-2030)
• Table 33: Pulmonology Devices Market in South Korea (2021-2030)
• Table 34: Pulmonology Devices Market in Rest of Asia Pacific (2021-2030)
• Table 35: Pulmonology Devices Market in Rest of the World (2021-2030)
• Table 36: Pulmonology Devices Market in Rest of the World by Product Type (2021-2030)
• Table 37: Pulmonology Devices Market in Rest of the World by End User (2021-2030)
• Table 38: Pulmonology Devices Market in Rest of the World by Country (2021-2030)
• Table 39: Pulmonology Devices Market in Middle East (2021-2030)
• Table 40: Pulmonology Devices Market in Africa (2021-2030)
• Table 41: Pulmonology Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis in Pulmonology Devices Market
• Figure 3: Pulmonology Devices Market in Global (2021-2030)
• Figure 4: Pulmonology Devices Market in Global by Product Type (2021-2030)
• Figure 5: Pulmonology Devices Market in Global by End User (2021-2030)
• Figure 6: Pulmonology Devices Market in Global by Geography (2021-2030)
• Figure 7: Pulmonology Devices Market in North America (2021-2030)
• Figure 8: Pulmonology Devices Market in North America by Product Type (2021-2030)
• Figure 9: Pulmonology Devices Market in North America by End User (2021-2030)
• Figure 10: Pulmonology Devices Market in North America by Country (2021-2030)
• Figure 11: Pulmonology Devices Market in the US (2021-2030)
• Figure 12: Pulmonology Devices Market in Canada (2021-2030)
• Figure 13: Pulmonology Devices Market in Mexico (2021-2030)
• Figure 14: Pulmonology Devices Market in Europe (2021-2030)
• Figure 15: Pulmonology Devices Market in Europe by Product Type (2021-2030)
• Figure 16: Pulmonology Devices Market in Europe by End User (2021-2030)
• Figure 17: Pulmonology Devices Market in Europe by Country (2021-2030)
• Figure 18: Pulmonology Devices Market in France (2021-2030)
• Figure 19: Pulmonology Devices Market in Germany (2021-2030)
• Figure 20: Pulmonology Devices Market in UK (2021-2030)
• Figure 21: Pulmonology Devices Market in Italy (2021-2030)
• Figure 22: Pulmonology Devices Market in Spain (2021-2030)
• Figure 23: Pulmonology Devices Market in Russia (2021-2030)
• Figure 24: Pulmonology Devices Market in Rest of Europe (2021-2030)
• Figure 25: Pulmonology Devices Market in Asia Pacific (2021-2030)
• Figure 26: Pulmonology Devices Market in Asia Pacific by Product Type (2021-2030)
• Figure 27: Pulmonology Devices Market in Asia Pacific by End User (2021-2030)
• Figure 28: Pulmonology Devices Market in Asia Pacific by Country (2021-2030)
• Figure 29: Pulmonology Devices Market in China (2021-2030)
• Figure 30: Pulmonology Devices Market in Japan (2021-2030)
• Figure 31: Pulmonology Devices Market in India (2021-2030)
• Figure 32: Pulmonology Devices Market in Australia (2021-2030)
• Figure 33: Pulmonology Devices Market in South Korea (2021-2030)
• Figure 34: Pulmonology Devices Market in Rest of Asia Pacific (2021-2030)
• Figure 35: Pulmonology Devices Market in Rest of the World (2021-2030)
• Figure 36: Pulmonology Devices Market in Rest of the World by Product Type (2021-2030)
• Figure 37: Pulmonology Devices Market in Rest of the World by End User (2021-2030)
• Figure 38: Pulmonology Devices Market in Rest of the World by Country (2021-2030)
• Figure 39: Pulmonology Devices Market in Middle East (2021-2030)
• Figure 40: Pulmonology Devices Market in Africa (2021-2030)
• Figure 41: Pulmonology Devices Market in South America (2021-2030)
• Figure 42: Market Drivers
• Figure 43: Market Barriers
• Figure 44: Market Opportunities
• Figure 45: PORTER'S Five Force Analysis

Pulmonology Devices Market By Product Type (Pulmonary Biopsy Devices [Single-Use Forceps, Cytology Brushes, Microbiology Brushes], Endobronchial Ultrasound (Ebus) Needles [Endobronchial Ultrasound Fine Biopsy Needles, Endobronchial Ultrasound Transbronchial Aspiration Needles], Pulmonology Devices [Intensive Care Pulmonology Devices, Portable/Transportable Pulmonology Devices], Bronchoscopes [Video, Fiber], Airway Stents Systems, Oxygen Concentrators, Nebulizers, Spirometers, Airway Extraction Baskets, Pulse Oximeters, Pulmonary Balloon Catheters, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to outbreak of covid-19 pandemic and increasing prevalence of respiratory diseases

Global Pulmonology Devices Market will grow at a CAGR of 10.50% during the forecast period from 2024 to 2030. The Pulmonology Devices Market is witnessing positive growth owing to the rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, lung cancer, the outbreak of COVID-19 pandemic, growing adoption of minimally invasive procedures, rapid technical innovation in product development, thereby contributing to the growth of the Pulmonology Devices market during the forecast period from 2024 to 2030.

Pulmonology Devices Market Dynamics:

Pulmonology Devices Market has significantly risen owing to the outbreak of the COVID-19 pandemic. The demand for Pulmonology Devices is increasing at present, as these devices have been extensively used by the population for the deadly disease.

The continuous rise in the COVID-19 cases across the globe is expected to increase the demand for Pulmonology Devices to manifolds. For instance, as per the World Health Organization (WHO), as of 14 February 2022, there have been 410,565,868 confirmed cases of COVID-19.

In addition, the above data also mentioned that the US, India, Brazil, the UK, and France are the five countries that were severely affected by Covid-19.

Furthermore, the emergence of new strains such as the Omicron variant first reported to WHO from South Africa on 24 November 2022 could also increase the adoption of the Pulmonology Devices among various countries for early screening at home.

Moreover, increasing awareness among the population regarding applications of Pulmonology Devices in COVID-19 management is also likely to fuel the Global Pulmonology Devices market.

With proper systems, disease management becomes better. Therefore, the increasing cases of COVID-19 are projected to result in the growing demand for Pulmonology Devices, thereby contributing to the growth of the Pulmonology Devices market during the forecast period from 2024 to 2030.

Another factor responsible for the growth of the Pulmonology devices market is the growing burden of respiratory diseases across the globe. Respiratory diseases are among the leading causes of death in the world. Chronic obstructive pulmonary disease (COPD) is the third-most-leading cause of death, causing 3.23 million deaths worldwide in 2019, as per World Health Organization (WHO). As per the same statistics, environmental exposure to tobacco smoke, indoor air pollution, and occupational dust, fumes, and chemicals are important risk factors for COPD. Thus, the burgeoning cases of COPD will contribute to the Global Pulmonology Devices Market growth.

Further, many companies have scaled up their manufacturing capacity to meet the rising demand. For instance, in March 2020, Zoll Medical Corporation executed a plan to increase manufacturing capacity to 10,000 Ventilators per month. This production volume expansion helped in the treatment of patients suffering from COVID-19 and ultimately led to market expansion. It is further expected that there will be a surge in the number of patients requiring ventilation support, and there may be an increase in the demand for Pulmonology Devices, which might fasten the pace of the Pulmonology Devices market growth.

Certain factors such as the problems associated with the use of invasive equipment, and the high cost of endosurgical procedures pose a minor hurdle for the growth of the pulmonology devices market.

Pulmonology Devices Market Segment Analysis:

Pulmonology Devices Market by Product Type (Pulmonary Biopsy Devices [Single-use Forceps, Cytology Brushes, Microbiology Brushes], Endobronchial Ultrasound (EBUS) Needles [Endobronchial Ultrasound Fine Biopsy Needles, Endobronchial Ultrasound Transbronchial Aspiration Needles], Ventilators [Intensive Care Ventilators, Portable/Transportable Ventilators], Bronchoscopes [Video, Fiber], Airway Stents Systems, Oxygen Concentrators, Nebulizers, Spirometers, Airway Extraction Baskets, Pulse Oximeters, Pulmonary Balloon Catheters, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and Pulmonology Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Pulmonology Devices Market by Product Type segment, in the Ventilators subsegment, the Portable/Transportable Ventilators is the fastest growing in the Global Pulmonology Devices market during the forecast period from 2024 to 2030.

The rapid growth of this product segment can be attributed to their widespread use in hospitals owing to their convenience, faster, and continuous care to patients even before their arrival in the hospital premises.

Since the beginning of the COVID-19 pandemic, the demand for Portable Ventilators has been on the rise. Therefore, the growing demand for disease treatment benefits the portable ventilator market, even if the procedure is delayed.

Additionally, innovators are coming up with lightweight, cost-effective ventilators to tackle COVID-19. For instance, in 2020, Marico Innovation Foundation has offered Rs 85 lakhs to winners of an innovation challenge for developing unique, disruptive, accessible, and affordable ventilators.

In addition, new product approvals are also likely to upsurge the Ventilators market during the forecasted period. For instance, in August 2022, the Max Ventilator announced the launch of the High Flow oxygen Therapy (HFOT) device and WeanX in its new ventilator range category.

Moreover, new/existing hospitals and healthcare centers in rural regions of developing countries such as India, China, Brazil, are equipping with advanced facilities for patient comfort, which is expected to enhance the market potential.

Hence, all the above-mentioned factors are expected to drive the segment growth of the Ventilators market as the demand is rising owing to the rising diseases requiring ventilation support.

North America is expected to dominate the overall Pulmonology Devices Market:

North America is expected to dominate the overall Pulmonology Devices market during the forecast period. This domination is due to the increase in the patient population suffering from various chronic respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disorder, and others in the region.

For instance, as per the Centers for Disease Control and Prevention 2022 data, the age-adjusted prevalence of COPD among adults in the US during 2019 varied considerably by state, from <4.5% in California, Colorado, Hawaii, Massachusetts, Minnesota, and Utah to >9% in Alabama, Arkansas, Kentucky, and West Virginia.

Moreover, burgeoning cases of Covid-19 in the country is also expected to surge the demand for Pulmonology Devices in the upcoming years. For instance, as per the WHO latest report, 14 February 2022, there have been 143,190,545 confirmed cases of COVID-19 in the country.

Further, the US represents the largest market worldwide supported by developed healthcare infrastructure and rising adoption of advanced non-invasive patient monitoring technologies. In addition presence of key market players such as Boston Scientific Corporation, Medtronic, Pentax Medical, among others is also expected to boost the market.

Also, advanced product launches and commercialization agreements among the key companies are further expected to fuel the market. For instance, recently in March 2022, Nonin Medical, Inc. launched two new disposable products - a single-use wristband and a sensor for use with Nonin's WristOx2 3150, wrist-worn pulse oximeter (SpO2). Moreover, in May 2022, California-based CorVent Medical announced that it received CE mark approval for its Respond-19 ventilator and is preparing to launch it in Europe. The system received FDA emergency use authorization (EUA) for primary critical care use in December 2020 and is expected to propel the market growth of Pulmonology Devices.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Pulmonology Devices market during the forecast period.

Pulmonology Devices Market Key Players:

Some of the key market players operating in the Pulmonology Devices market include PENTAX Medical (Hoya Corporation), Boston Scientific Corporation, Medtronic, Ambu A/S, CONMED Corporation, Koninklijke Philips N.V., Cook, Medi-Globe GmbH, Getinge AB, ResMed, KARL STORZ SE & Co. KG, Verathon Inc, Olympus Corporation, Richard Wolf GmbH, FUJIFILM Corporation, Dragerwerk AG & Co. KGaA, Smiths Group PLC, SCHILLER AG, General Electric Company, ACE Medical Devices Pvt. Ltd. among others.

Recent Developmental Activities in the Pulmonology Devices Market:

On September 25, 2022, Emerson announced a partnership with BioBusiness, an Egyptian medical equipment manufacturer, to design and produce a variety of Ventilators that will use Emerson's ASCO(TM) valves and AVENTICS(TM) regulators to offer accurate pressure and gas flow control.

On January 21, 2022, artificial intelligence-powered Fingertip Pulse Oximeter (SpO2) by TytoCare Ltd was launched which enables remote monitoring at the time of the COVID crisis.

On August 28, 2022, Ventilator maker Max Ventilator entered into a technology collaboration agreement with US-based respiratory technology player Amptron Medical to match global standards.

Key Takeaways from the Pulmonology Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024 to 2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Pulmonology Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Pulmonology Devices Market.

Various opportunities are available for the other competitor in the Pulmonology Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Pulmonology Devices market growth in the coming future?

Target Audience who can be benefited from this Pulmonology Devices Market Ket Report Study

Pulmonology Devices providers

Research organizations and consulting companies

Pulmonology Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Pulmonology Devices

Various End-users want to know more about the Pulmonology Devices Market and the latest technological developments in the Pulmonology Devices market.

Frequently Asked Questions for Pulmonology Devices Market:

1. What are Pulmonology Devices?

Pulmonology Devices are devices used for diagnosing and treating diseases of the lungs and other parts of the respiratory system.

2. What is the market for Global Pulmonology Devices?

Global Pulmonology Devices Market will grow at a CAGR of 10.50% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Pulmonology Devices?

The major drivers for Pulmonology Devices are the rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, lung cancer, the outbreak of COVID-19 pandemic, growing adoption of minimally invasive procedures, rapid technical innovation in product development.

4. What are the key players operating in Global Pulmonology Devices?

Some of the key market players operating in the Pulmonology Devices market include PENTAX Medical (Hoya Corporation), Boston Scientific Corporation, Medtronic, Ambu A/S, CONMED Corporation, Koninklijke Philips N.V., Cook, Medi-Globe GmbH, Getinge AB, ResMed, KARL STORZ SE & Co. KG, Verathon Inc, Olympus Corporation, Richard Wolf GmbH, FUJIFILM Corporation, Dragerwerk AG & Co. KGaA, Smiths Group PLC, SCHILLER AG, General Electric Company, ACE Medical Devices Pvt. Ltd. and others.

5. Which regions has the highest share in the Pulmonology Devices market?

North America is expected to dominate the overall Pulmonology Devices market during the forecast period,2024 to 2030. This domination is due to the increase in the patient population suffering from various chronic respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disorder, and others, the outbreak of the COVID-19 pandemic in the region.

Table of Contents

1.Pulmonology Devices Market Report Introduction

2.Pulmonology Devices Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Pulmonology Devices Market Key factors analysis

• 4.1. Pulmonology Devices Market Drivers
  • 4.1.1. Outbreak of COVID-19
  • 4.1.2. Rising Prevalence of Respiratory Diseases
  • 4.1.3. Growing Adoption of Minimally Invasive Procedures
  • 4.1.4. Technical Innovation in Product Development
• 4.2. Pulmonology Devices Market Restraints and Challenges
  • 4.2.1. Problems associated with the Use of Invasive Equipment
  • 4.2.2. The High Cost of Endosurgical Procedures
• 4.3. Pulmonology Devices Market Opportunities
  • 4.3.1. Growth Opportunities in Emerging Countries
  • 4.3.2. Growing Demand for Patient Monitoring in Non-Hospital Settings

5. Pulmonology Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Pulmonology Devices Market

7. Pulmonology Devices Market layout

• 7.1. By Product Type
  • 7.1.1. Pulmonary Biopsy Devices
    • 7.1.1.1. Single-use Forceps
    • 7.1.1.2. Cytology Brushes
    • 7.1.1.3. Microbiology Brushes
  • 7.1.2. Endobronchial Ultrasound (EBUS) Needles
    • 7.1.2.1. Endobronchial Ultrasound Fine Biopsy Needles
    • 7.1.2.2. Endobronchial Ultrasound Transbronchial Aspiration Needles
  • 7.1.3. Ventilators
    • 7.1.3.1. Intensive Care Ventilators
    • 7.1.3.2. Portable/Transportable Ventilators
  • 7.1.4. Bronchoscopes
    • 7.1.4.1. Video
    • 7.1.4.2. Fiber
  • 7.1.5. Airway Stents Systems
  • 7.1.6. Oxygen Concentrators
  • 7.1.7. Nebulizers
  • 7.1.8. Spirometers
  • 7.1.9. Airway Extraction Baskets
  • 7.1.10. Pulse Oximeters
  • 7.1.11. Pulmonary Balloon Catheters
  • 7.1.12. Others
• 7.2. By End User
  • 7.2.1. Hospitals and Clinics
  • 7.2.2. Ambulatory Surgical Centers
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. North America Pulmonology Devices Market, by Product Type
    • 7.3.1.2. North America Pulmonology Devices Market, by End User
    • 7.3.1.3. North America Pulmonology Devices Market, by Country
    • 7.3.1.3.1. United States
    • 7.3.1.3.2. Canada
    • 7.3.1.3.3. Mexico
  • 7.3.2. Europe
    • 7.3.2.1. Europe Pulmonology Devices Market, by Product Type
    • 7.3.2.2. Europe Pulmonology Devices Market, by End User
    • 7.3.2.3. Europe Pulmonology Devices Market, by Country
    • 7.3.2.3.1. France
    • 7.3.2.3.2. Germany
    • 7.3.2.3.3. United Kingdom
    • 7.3.2.3.4. Italy
    • 7.3.2.3.5. Spain
    • 7.3.2.3.6. Russia
    • 7.3.2.3.7. Rest of Europe
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. Asia-Pacific Pulmonology Devices Market, by Product Type
    • 7.3.3.2. Asia-Pacific Pulmonology Devices Market, by End User
    • 7.3.3.3. Asia-Pacific Pulmonology Devices Market, by Country
    • 7.3.3.3.1. China
    • 7.3.3.3.2. Japan
    • 7.3.3.3.3. India
    • 7.3.3.3.4. Australia
    • 7.3.3.3.5. South Korea
    • 7.3.3.3.6. Rest of Asia Pacific
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. RoW Pulmonology Devices Market, by Product Type
    • 7.3.4.2. RoW Pulmonology Devices Market, by End User
    • 7.3.4.3. RoW Pulmonology Devices Market, by Region
    • 7.3.4.3.1. Middle East
    • 7.3.4.3.2. Africa
    • 7.3.4.3.3. South America

8. Pulmonology Devices Global Company Share Analysis - Key 3-5 Companies

9. Pulmonology Devices Company and Product Profiles

• 9.1. PENTAX Medical (Hoya Corporation)
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Boston Scientific Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Medtronic
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4. Ambu A/S
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. CONMED Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Koninklijke Philips N.V.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Cook
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Medi-Globe GmbH
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Getinge AB
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. ResMed
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. KARL STORZ SE & Co. KG
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Verathon Inc
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Olympus Corporation
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Richard Wolf GmbH
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. FUJIFILM Corporation
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. Dragerwerk AG & Co. KGaA
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Smiths Group PLC
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. SCHILLER AG
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. General Electric Company
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. ACE Medical Devices Pvt. Ltd.
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us